Navigation Links
MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
Date:10/29/2012

KENNESAW, Ga., Oct. 29, 2012 /PRNewswire/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended September 30, 2012.

Highlights of Third Quarter 2012 Results include:

  • Revenue Increased by more than 3.5 times over Third Quarter of 2011
  • Quarter over Quarter Revenue increased by 63%
  • Gross Margins Hit Record Level of 82%

    • The Company recorded record revenue of $8.0 million for the third quarter of 2012, a 270% or $5.8 million increase over third quarter of 2011 revenue of $2.2 million, and a 63% increase over second quarter of 2012 revenue of $4.9 million.  The Company's earnings before interest, taxes, depreciation, amortization and share-based compensation (Adjusted EBITDA*) for the quarter ended September 30, 2012, were $726,000, a $1.7 million improvement as compared to the Adjusted EBITDA* loss of $934,000 for the third quarter of 2011.

    For the nine months ended September 30, 2012, the Company recorded revenue of $16.5 million, more than threefold increase over revenue of $5.1 million for the first nine months of 2011. The Company's Adjusted EBITDA* for the nine months ended September 30, 2012 was $2.0 million, a $6.6 million improvement over Adjusted EBITDA* loss of $4.7 million for the first nine months of 2011.

    For the 7th consecutive quarter, the Company reported improved gross profit margins. The Company's third quarter 2012 gross margins of 82% is nearly a twenty-three percentage point improvement over third quarter of 2011 gross margins of 59%, and a six percentage point improvement over the Company's second quarter of 2012 gross margins of 77%. 

    Management Comm
    '/>"/>

    SOURCE MiMedx Group, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related biology technology :

    1. MiMedx Group, Inc. to Present at the 6th Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders Conference
    2. MiMedx Group Completes $5,000,000 Private Placement
    3. MiMedx Group, Inc. Receives CE Certification for Its CollaFix™ Surgical Mesh CD
    4. MiMedx to Present at American Academy of Orthopaedic Surgeons Annual Meeting
    5. MiMedx Group Announces 2011 Results
    6. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
    7. MiMedx Exceeds Revenue Goal for First Quarter of 2012
    8. MiMedx Group Announces Record First Quarter Results
    9. MiMedx Group, Inc. Announces Release Date for 2012 Second Quarter Results
    10. MiMedx Group Announces Record Second Quarter Results
    11. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/21/2013)... Emerson Resources Inc. , a premier ... the Company’s Chief Executive Officer and Chairman of the ... of service. As part of Emerson Resources’ planned leadership ... named as Dr. Signorino’s successor. , Dr. Signorino ... made a significant contribution to the field during his ...
    (Date:5/21/2013)... Minneapolis, MN (PRWEB) May 21, 2013 ... a patented automatic colony counter, announced today that they ... four products , the IncuCount, IntelliCount, InCount and ... price and sophistication are especially useful in food microbiology ... been given an updated look. A bright white ...
    (Date:5/21/2013)... SoundConnect is pleased to announce the release ... in Canada. Lync is the next generation of ... and organizations to collaborate and communicate much more easily ... the United States. With the progressive rollout of Lync ... Canada, SoundConnect now offers a complete Microsoft Lync solution ...
    (Date:5/20/2013)... May 21, 2013 Grace Century ... in “game-changing” life science and health related private equity ... to its International Project Team. Dergham's expertise in finance ... multi-cultural depth to Grace Century as it continues to ... , Ms. Dergham holds both an under graduate degree ...
    Breaking Biology Technology:Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3Dalia Dergham Joins Grace Century FZ LLC International Project Team 2
    ... N.Y., April 9 Is the United ... to study in a post-9/11 America? What,are ... international talent for,American biotechnology research and industrial ... in the department of biomedical,engineering at Boston ...
    ... acquire common stock held by American Red Cross, in ... ProMetic,s stake in PRDT to 77%, - American Red ... of PRDT, MONTREAL and CAMBRIDGE, England, April 9 ... ProMetic,has signed a Letter of Intent ("LOI") to acquire ...
    ... Inc. (TSX:,ARI), a biotechnology company discovering and developing the next wave ... Where: St. Andrew,s Club & Conference Centre, S7 ... 150 King Street West, 27th Floor, Toronto, Ontario, When: ... Webcast: ARIUS Research Inc.,s Annual and Special Meeting will be webcast ...
    Cached Biology Technology:ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 2ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 3ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 4ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 5ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 6ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 7ARIUS 2008 Annual and Special Meeting of Shareholders 2
    (Date:5/21/2013)... keeping in shape is an uphill battle? Try staying ... prolonged weightlessness withers muscle and bone. , That,s the ... address with a new three-year, $1.2 million grant from ... exercise during multiyear exploratory missions. , "You could give ... you can,t get them to stick to it, it ...
    (Date:5/21/2013)... CAMBRIDGE, MA -- Over the past few decades, scientists ... including angioplasty balloons and metallic stents. While generally effective, ... of side effects. , A new study from MIT ... combines the benefits of angioplasty balloons and drug-releasing stents, ... a balloon is inflated in the artery for only ...
    (Date:5/21/2013)... Australian scientists have charted the path of insulin action ... provides a comprehensive blueprint for understanding what goes wrong ... Sean Humphrey and Professor David James from Sydney,s Garvan ... early online edition of the prestigious journal Cell ... hormone plays a very important role in the body ...
    Breaking Biology News(10 mins):Fueling fitness on the final frontier 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
    ... of Illinois at Chicago have identified a novel function for ... in acute respiratory distress syndrome, also known as ARDS. ... and treatment of lung inflammation and injury. The research will ... this year and online June 29. ARDS is an ...
    ... exacerbate drought events throughout the world, resulting in large-scale ... addition, periods of drought vary from year to year ... to adapt to more severe conditions. Many modern ... However, evolution and cultivation in the cold, dry Andean ...
    ... gardens, we watch them turn gradually from hard, green ... This familiar and seemingly commonplace transformation masks a seething ... complex manner. For generations, agriculturalists and scientists have ... nutrient composition, more or less, one trait at a ...
    Cached Biology News:UIC researchers make promising finding in severe lung disease 2Drought tolerance in potatoes 2Drought tolerance in potatoes 3The 21st century tomato 2The 21st century tomato 3
    ... salt solution. It is routinely used as an ... blood at refrigerator temperatures for approximately 10 weeks.1 ... collected into a container of this product and ... in a refrigerator at 2-8 C for 2 ...
    ... OligoMix or individual RNA sequences from high throughput ... small RNAs from LC Sciences. These products provide ... millions) of DESIGNED sequences delivered in a microtube ... containing a single verified RNA sequence. This is ...
    ... Chromatograph/Mass Spectrometer, utilizing many of the ... offers high throughput and excellent productivity, ... ratio. Like the GCMS-QP2010 Plus, the ... for optimum separation, 20 temperature ramps, ...
    ... Assay Kit contains all reagents necessary to ... lineage, as determined by staining for mineralization. ... necessary reagents and a protocol for quantifying ... product is useful for studying the effects ...
    Biology Products: